<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Saline infusion sonohysterography</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Saline infusion sonohysterography</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Saline infusion sonohysterography</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steven R Goldstein, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert L Barbieri, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Deborah Levine, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 18, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">Saline</a> infusion sonohysterography refers to a procedure in which fluid is instilled into the uterine cavity transcervically to provide enhanced endometrial visualization during transvaginal ultrasound examination [<a href="#rid1">1,2</a>]. The technique improves sonographic detection of endometrial pathology, such as polyps, hyperplasia, cancer, leiomyomas, and adhesions. In addition, it can help avoid invasive diagnostic procedures in some patients as well as optimize the preoperative triage process for those women who require therapeutic intervention. It is easily and rapidly performed at minimal cost, well-tolerated by patients, and is virtually devoid of complications. The American College of Obstetricians and Gynecologists (ACOG), in conjunction with the American College of Radiology and the American Institute of Ultrasound in Medicine, developed a technology assessment document for saline infusion sonohysterography [<a href="#rid3">3,4</a>]. </p><p class="headingAnchor" id="H2"><span class="h1">INDICATIONS</span><span class="headingEndMark"> — </span>There are a number of situations where fluid enhanced endovaginal scanning will aid evaluation of the uterine cavity. The American Institute for Ultrasound in Medicine's standard indications and contraindications to this procedure are shown in the table (<a class="graphic graphic_table graphicRef73097" href="/d/graphic/73097.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H3"><span class="h2">Unscheduled uterine bleeding</span><span class="headingEndMark"> — </span>Unexpected uterine bleeding accounts for a large proportion of gynecologic patient visits. Endometrial biopsy and/or office hysteroscopy are often used as initial diagnostic procedures; in hospital dilation and curettage is no longer considered an appropriate initial diagnostic test in most women [<a href="#rid5">5</a>].</p><p>Transvaginal ultrasound is used increasingly as an initial triage for patients with abnormal uterine bleeding. Sonohysterography is a subset of transvaginal sonography that is used when it is difficult to visualize the endometrium or the endometrium is thickened.</p><p>Sonohysterography is particularly useful for finding focal endometrial abnormalities or confirming that a focal abnormality diagnosed by transabdominal or transvaginal ultrasound is present and better defining the nature of the abnormality [<a href="#rid6">6,7</a>]. As an example, one study performed both transvaginal ultrasonographic examination and sonohysterography on 106 patients with menometrorrhagia [<a href="#rid8">8</a>]. The sensitivity and specificity of <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> infusion sonohysterography for detection of polyps were significantly higher than for transvaginal ultrasound alone (93 and 94 versus 75 and 76 percent for transvaginal sonography) and were comparable to hysteroscopy, a finding confirmed by others [<a href="#rid9">9-12</a>].</p><p>In addition, a prospective series of 214 consecutive pre- and postmenopausal women with abnormal uterine bleeding and a suspected uterine abnormality on transvaginal sonography found an initial approach of sonohysterography followed by hysteroscopy, if needed for diagnosis or therapy, was preferable to routinely proceeding to diagnostic hysteroscopy because the latter could be avoided in 84 percent of patients (sonohysterography was conclusive in 180 of 214 women) [<a href="#rid13">13</a>]. Although some women subsequently underwent operative hysteroscopy for treatment of uterine abnormalities, an initial approach using diagnostic non-office-based hysteroscopy under conditions allowing operative hysteroscopy if needed was also deemed unsatisfactory because preparation for the combined procedure requires general or regional anesthesia, despite the knowledge that a significant portion of women will have no anatomic abnormality and will not have a surgical intervention.</p><p>In addition, sonohysterography can help to reliably distinguish between:</p><p class="bulletIndent1"><span class="glyph">●</span>Premenopausal women with anovulatory bleeding, which is best treated hormonally, from those with an anatomic lesion, which may require tissue sampling for histologic diagnosis and/or resection for treatment [<a href="#rid14">14</a>]. (See  <a class="medical medical_review" href="/d/html/3263.html" rel="external">"Abnormal uterine bleeding in nonpregnant reproductive-age patients: Terminology, evaluation, and approach to diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Postmenopausal women with bleeding due to atrophy, the most common cause of bleeding in this age group, from those with anatomic lesions that might require tissue sampling to exclude carcinoma or for treatment. (See  <a class="medical medical_review" href="/d/html/5421.html" rel="external">"Approach to the patient with postmenopausal uterine bleeding"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with focal abnormalities best biopsied under direct hysteroscopic visualization from those with global abnormalities that can be sampled blindly [<a href="#rid6">6</a>].</p><p></p><p>Women with abnormal uterine bleeding in whom endometrial sampling is indicated should have <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> instillation sonohysterography or office hysteroscopy prior to the sampling procedure. Blind sampling procedures are justified if an abnormality is symmetrically "pan uterine." When focal lesions (eg, polyps, fibroids, some hyperplasias, some carcinomas) are detected, then directed biopsies are preferable.</p><p class="headingAnchor" id="H4"><span class="h2">Infertility</span><span class="headingEndMark"> — </span>Endometrial assessment is part of the routine evaluation of infertility and recurrent pregnancy loss (see  <a class="medical medical_review" href="/d/html/7396.html" rel="external">"Overview of infertility"</a> and  <a class="medical medical_review" href="/d/html/5436.html" rel="external">"Recurrent pregnancy loss: Evaluation"</a>). <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">Saline</a> infusion sonohysterography is useful for detecting potential anatomic causes of reduced fertility, such as submucous myomas, endometrial polyps, anomalies, and intrauterine adhesions and appears comparable to or better than hysterosalpingography (HSG) or hysteroscopy [<a href="#rid1">1,2,15-18</a>].</p><p>However, an outline of the fallopian tubes (as seen with HSG) is not observed with sonohysterography. Accretion of instilled fluid in the posterior cul-de-sac is a sign of patency of at least one tube.</p><p class="headingAnchor" id="H3018952792"><span class="h2">Hysterosalpingo–contrast sonography (HyCoSy)</span><span class="headingEndMark"> — </span>HyCoSy is a variation of sonohysterography that is mainly used to determine tubal patency in patients desiring pregnancy and confirm tubal occlusion after sterilization procedures [<a href="#rid18">18,19</a>]. Contraindications for HyCoSy are similar to those of traditional sonohysterography. For the procedure, sterile <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> mixed with air, contrast, or foam is manually injected into the cervix, uterus, and fallopian tubes while observing with real-time ultrasound imaging [<a href="#rid19">19-21</a>]. Commercial devices that mix air and saline together to form the air-infused saline available; similar results can be achieved by filling a 30 mL syringe with half saline and half air and then rocking the syringe up and down while pushing the plunger to infuse air with saline. Use of a balloon catheter can reduce fluid backflow during the procedure.</p><p class="headingAnchor" id="H5"><span class="h2">Tamoxifen-induced changes</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9972" href="/d/drug information/9972.html" rel="external">Tamoxifen</a>, a potent antiestrogen, is being used extensively as adjunctive chemotherapy in women with estrogen receptor-positive breast cancer. Some patients taking tamoxifen, when viewed with endovaginal ultrasound, will display thickened central uterine echoes. These changes are sometimes polyps or abnormal endometrial tissue (proliferative, hyperplasia, or even cancer). However, sonohysterography has shown that these changes can often represent microcysts of the basalis of the endometrium or proximal myometrium that develop due to reactivation of focal adenomyosis [<a href="#rid22">22</a>]. Thus, sonohysterography can help to define suspected endometrial abnormalities noted on transvaginal ultrasound examination and avoid tissue sampling (<a class="graphic graphic_diagnosticimage graphicRef70071 graphicRef62592" href="/d/graphic/70071.html" rel="external">image 1A-B</a> and <a class="graphic graphic_picture graphicRef80525" href="/d/graphic/80525.html" rel="external">picture 1</a>) [<a href="#rid23">23-25</a>].</p><p>Routine sonographic screening of the endometrium of asymptomatic women taking <a class="drug drug_general" data-topicid="9972" href="/d/drug information/9972.html" rel="external">Tamoxifen</a> has not been recommended by the American College of Obstetricians and Gynecologists (ACOG) [<a href="#rid26">26</a>]. This is a controversial area; some investigators have proposed that patients embarking on tamoxifen therapy should have pretreatment screening to determine if they have underlying endometrial abnormalities, such as polyps or endometrial hyperplasia, which place them at high risk of developing into or progressing to atypical hyperplasia. Such patients warrant ongoing periodic surveillance, which is best accomplished by transvaginal ultrasound and then sonohysterography if the endometrial echo is not adequately seen or not reliably thin [<a href="#rid27">27</a>]. Low risk patients could be followed according to the ACOG guidelines, which are briefly described above and in detail elsewhere.  </p><p class="headingAnchor" id="H6"><span class="h1">TECHNIQUE</span><span class="headingEndMark"> — </span>The examination is typically scheduled early in the follicular phase of the cycle, after menstrual flow has ceased and before day 10, as the endometrium is very thin at this point in the cycle. Later in the cycle, focal irregularities in the contour of the endometrium may be mistaken for small polyps or focal areas of endometrial hyperplasia (<a class="graphic graphic_diagnosticimage graphicRef74592" href="/d/graphic/74592.html" rel="external">image 2</a>). One prospective blinded study reported a 27 percent false-positive rate in sonohysterography performed from day 16 to 28, but no false-positive when the procedure was performed prior to day 10 [<a href="#rid28">28</a>]. Sometimes the patient has such irregular bleeding that she cannot tell what is an actual menses. In such cases, it can be helpful to use an empiric course of a progestin, such as <a class="drug drug_general" data-topicid="9600" href="/d/drug information/9600.html" rel="external">medroxyprogesterone acetate</a> 10 mg daily for 10 days, to create a "medical curettage" and then time the ultrasound evaluation to the withdrawal bleed.</p><p>Anesthesia or analgesia is not required as the intrauterine insemination catheter is relatively painless while being inserted [<a href="#rid29">29</a>]. The procedure is well tolerated by the overwhelming majority of patients; a few experience minimal cramping.</p><p>A bimanual examination may be performed initially to determine the position and mobility of the uterus, although the initial transvaginal sonography can usually determine the degree of anteversion or retroversion, if present. The speculum is inserted and the cervix cleansed with a 10 percent iodine-based solution in patients who do not have an iodine allergy. A variety of commercially available sonohysterography catheters can be utilized. Most of these have similar efficacy but vary in small design elements [<a href="#rid30">30</a>]. Insertion can be with ring forceps, using a spear-like motion (for less flexible catheters), or with an internal stylet. To prevent run back of fluid, some employ an acorn-like device, and others have a balloon.</p><p>The catheter should be flushed with sterile <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> or water prior to insertion to rid it of small amounts of air, which would cause an echogenic artifactual appearance. The catheter is inserted to the fundus by grasping the catheter with a ring forceps and gently feeding it through the cervical os. The speculum is then removed carefully to avoid dislodging the catheter. The catheter will still extend beyond the introitus when positioned in the uterus.</p><p>The vaginal probe is then reinserted and a syringe filled with sterile fluid rid of air bubbles is attached to the catheter. Fluid is instilled while the transducer is moved from side to side (cornua to cornua) in a long axis projection. The amount of instilled fluid will vary, depending upon the image produced on the ultrasound monitor.</p><p>After the uterus has been completely surveyed from cornua to cornua in a long-axis projection, the transducer is rotated 90 degrees into a coronal plane. More fluid is instilled while fanning down towards the endocervical canal and up towards the uterine fundus to recreate three-dimensional anatomy. Every portion of the uterine cavity should be imaged, because polyps, hyperplasia, or carcinomas may be focal. A reliable assessment requires that the endometrial echo be homogeneous, surrounded by an intact hypoechoic junctional zone, and that the operator constantly remember that the endometrial cavity is a three-dimensional structure. Failure to meticulously recreate three dimensional anatomy will result in error.</p><p>Three-dimensional ultrasound equipment will eliminate error that may occur if the operator does not pay meticulous attention to mentally recreating three dimensional anatomy. It usually requires a balloon catheter to prevent run back of fluid and results in increased patient cramping and discomfort. A prospective study showed no advantage of three-dimension sonohysterography over two-dimensional [<a href="#rid31">31</a>], although both types had significantly better sensitivity and specificity than ultrasound without fluid enhancement.</p><p>Some initial reports utilizing a hydroxyethyl cellulose gel containing anesthetic and antiseptic agents have proposed this as an alternative to <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> or water. This may allow stable filling of the cavity without continuous injection [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H7"><span class="h1">FINDINGS</span><span class="headingEndMark"> — </span>A normal sonohysterogram is shown for comparison with the abnormalities below (<a class="graphic graphic_diagnosticimage graphicRef74520" href="/d/graphic/74520.html" rel="external">image 3</a>).</p><p class="headingAnchor" id="H8"><span class="h2">Polyp</span><span class="headingEndMark"> — </span>The typical sonohysterographic appearance of an endometrial polyp is a well-defined, homogeneous, polypoid lesion isoechoic to the endometrium with preservation of the endometrial-myometrial interface [<a href="#rid33">33</a>]. Atypical features include cystic components, multiple polyps, broad base, and hypoechogenicity or heterogeneity. Transvaginal sonograms before and after <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> infusion in a patient with abnormal uterine bleeding due to an endometrial polyp are provided (<a class="graphic graphic_diagnosticimage graphicRef63414 graphicRef71802" href="/d/graphic/63414.html" rel="external">image 4A-B</a>). In a meta-analysis of 25 studies comparing saline infusion sonohysterography with 2D transvaginal sonography, saline infusion studies had significantly greater sensitivity for the detection of endometrial polyps (92 versus 55 percent) while the specificity was similar for the two modalities (93 versus 91 percent) [<a href="#rid34">34</a>]. </p><p>The use of color flow or power Doppler for identifying the central feeder vessel pathognomonic of an endometrial polyp is an alternative to sonohysterography in the diagnosis of polyps (<a class="graphic graphic_diagnosticimage graphicRef57653" href="/d/graphic/57653.html" rel="external">image 5</a>). In one study, this techniques had a positive predictive value of 81.3 percent [<a href="#rid35">35</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Leiomyoma</span><span class="headingEndMark"> — </span>Submucosal fibroids are usually well-defined, broad-based, hypoechoic, solid masses with shadowing [<a href="#rid33">33</a>]. The overlying layer of endometrium is echogenic and distorts the endometrial-myometrial interface. Atypical features include pedunculation or a multilobulated surface. Sonohysterography's major benefit over transvaginal ultrasound alone is that it more accurately shows how much of the fibroid projects into the endometrial cavity (<a class="graphic graphic_diagnosticimage graphicRef55785 graphicRef50777" href="/d/graphic/55785.html" rel="external">image 6A-B</a>) [<a href="#rid33">33,36</a>]. In a meta-analysis of five studies, the pooled sensitivity and specificity of 2D <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> infusion sonohysterography for the detection of submucosal leiomyomas were 94 percent (95% CI 89-97 percent) and 81 percent (95% CI 76-86 percent) [<a href="#rid37">37</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Hyperplasia and cancer</span><span class="headingEndMark"> — </span>Endometrial hyperplasia usually appears as diffuse echogenic endometrial thickening without focal abnormality, although focal lesions can occur (<a class="graphic graphic_diagnosticimage graphicRef75181 graphicRef60457" href="/d/graphic/75181.html" rel="external">image 7A-B</a> and <a class="graphic graphic_picture graphicRef81230" href="/d/graphic/81230.html" rel="external">picture 2</a>) [<a href="#rid33">33</a>]. Endometrial cancer is typically a diffuse process, but early cases can be focal and can appear as a polypoid mass.</p><p class="headingAnchor" id="H11"><span class="h2">Adhesions</span><span class="headingEndMark"> — </span>Adhesions usually appear as mobile, thin, echogenic bands that cut across the endometrial cavity [<a href="#rid33">33</a>]. Less commonly, they are thick, broad-based bands or completely obliterate the endometrial cavity (Asherman syndrome).</p><p class="headingAnchor" id="H5523488"><span class="h2">Adenomyosis</span><span class="headingEndMark"> — </span>Some studies have observed communication between the endometrial cavity and adenomyotic lesions during <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> infusion sonohysterography [<a href="#rid38">38</a>]. These were saline-filled defects extending from the endometrial cavity into the myometrium. Other experts claim that this entity is not adenomyotic, but rather represents a different process which has been named "endometrial-subendometrial myometrium unit disruption disease" and may have an influence on fertility and outcome of assisted reproductive techniques [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H5523531"><span class="h2">Endometrial assessment after non-resectoscopic endometrial ablation</span><span class="headingEndMark"> — </span>Non-resectoscopic endometrial ablation has become a popular alternative to hysterectomy for treatment of heavy menstrual bleeding. When patients who have undergone this type of procedure subsequently have abnormal premenopausal bleeding or postmenopausal bleeding, routine methods of endometrial evaluation are often suboptimal, including sonohysterography [<a href="#rid40">40</a>].</p><p class="headingAnchor" id="H12"><span class="h1">TECHNICAL CONCERNS</span></p><p class="headingAnchor" id="H13"><span class="h2">Difficulty passing the catheter</span><span class="headingEndMark"> — </span>Occasionally, it will be difficult to thread the flexible catheter into place because of cervical stenosis, uterine position, or abnormal uterine contour. Changing the toe of the speculum by moving the handle up or down may change the angle of the cervix with the fundus and will often allow successful insertion of the catheter. A catheter with a stylet or one made of less flexible material also can be useful. A cervical stabilizer rather than a standard tenaculum is another acceptable option. Medical or mechanical dilation may be necessary in some women.</p><p class="headingAnchor" id="H14"><span class="h2">Poor visualization</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">Saline</a> infusion sonohysterography, unlike hysteroscopy, does not require distension of the uterine cavity. Even a small ribbon of sonolucent fluid will allow good visualization of endometrial contents on either side of the fluid. However, women with a patulous cervix may not retain even the small amount of fluid needed to visualize the endometrium. Sometimes there is excessive leakage of fluid out the fallopian tubes. Slow injection of fluid using minimal pressure can sometimes overcome these problems.</p><p class="headingAnchor" id="H15"><span class="h2">Infection</span><span class="headingEndMark"> — </span>The risk of upper genital tract infection is similar to that with hysteroscopy or traditional hysterosalpingogram [<a href="#rid41">41,42</a>]. Obtaining appropriate cultures and prescribing prophylactic antibiotics depend upon the patient's risk factors and clinician preference. Risk factors for pelvic infection include women with multiple partners, having a partner with dysuria or urethral discharge, young age, and previous sexually transmitted disease or pelvic inflammatory disease. Routine use of prophylactic antibiotics is not warranted [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H16"><span class="h2">Dissemination of carcinoma</span><span class="headingEndMark"> — </span>Concerns regarding the dissemination of malignant cells during <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> infusion sonohysterography have been addressed in various studies [<a href="#rid44">44</a>]. In one study [<a href="#rid45">45</a>], 14 women with known endometrial cancer underwent sonohysterography in the operating room prior to their surgical hysterectomy and staging procedure. In cell washings, malignant cells could be identified in only 1/14 (7 percent) of cases.</p><p>In another similar study [<a href="#rid46">46</a>], 32 women with known carcinoma had sonohysterography in the operating room during their surgery. The fluid that spilled from the fallopian tubes was collected. Malignant cells were identified in only 2/32 (6 percent). (See  <a class="medical medical_review" href="/d/html/3232.html" rel="external">"Overview of the evaluation of the endometrium for malignant or premalignant disease", section on 'Risk of tumor dissemination'</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">False-positive findings</span><span class="headingEndMark"> — </span>False-positive findings (ie, suspected pathology not confirmed by hysteroscopy) have been attributed to blood clots, intrauterine debris, mucus plugs, shearing of normal endometrium, thickened endometrial folds, and misidentified endometrial fragments [<a href="#rid47">47,48</a>].</p><p class="headingAnchor" id="H18"><span class="h1">SIDE EFFECTS AND COMPLICATIONS</span><span class="headingEndMark"> — </span>Procedure-related side effects and complications are mild and uncommon. A prospective study of 1153 women age 23 to 64 years undergoing <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> infusion sonohysterography reported the following: failure to complete the procedure (7 percent), pelvic pain (3.8 percent), vagal symptoms (3.5 percent), nausea (1 percent), and postprocedure fever (0.8 percent) [<a href="#rid49">49</a>]. In patients who failed to complete the procedure, a second attempt on another day was always successful when these issues were addressed (eg, use of dilators for cervical stenosis, analgesia/local anesthesia for patients with significant discomfort).</p><p>Although a small proportion of women find sonohysterography painful, it is less painful than office hysteroscopy [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H2161032407"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/114191.html" rel="external">"Society guideline links: Female infertility"</a>.)</p><p class="headingAnchor" id="H19"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/8401.html" rel="external">"Patient education: Abnormal uterine bleeding (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H20"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">Saline</a> infusion sonohysterography is a procedure in which fluid is instilled into the uterine cavity transcervically to provide enhanced endometrial visualization during transvaginal ultrasound examination. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications</strong> – Common indications include abnormal uterine bleeding, suspected uterine cavity abnormalities (including congenital anomalies), and infertility (<a class="graphic graphic_table graphicRef73097" href="/d/graphic/73097.html" rel="external">table 1</a>). Contraindications include pregnancy and active pelvic infection. (See <a class="local">'Indications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Technique </strong>– The examination is scheduled when the endometrium will be as thin as possible from the last day or two of staining until three to four days after the bleeding has ended. Anesthesia or analgesia is generally not required. Prior to insertion, the catheter is flushed with sterile <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> or water prior to get rid of small amounts of air that could result in visual artifact. The vaginal probe is then inserted, a syringe filled with sterile fluid without air bubbles is attached to the catheter, and fluid is instilled while the transducer is moved from side to side (cornua to cornua) in a long axis projection. (See <a class="local">'Technique'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infection risk</strong> – The risk of upper genital tract infection is similar to that with a traditional hysterosalpingogram. Whether cultures are obtained and prophylactic antibiotics prescribed depends upon the patient's risk factors and clinician preference. (See <a class="local">'Infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>False-positive findings</strong> – False-positive findings have been attributed to blood clots, intrauterine debris, mucus plugs, shearing of normal endometrium, thickened endometrial folds, and misidentified endometrial fragments. (See <a class="local">'False-positive findings'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Side effects</strong> – Procedure-related side effects and complications are mild and uncommon. (See <a class="local">'Side effects and complications'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Parsons AK, Lense JJ. Sonohysterography for endometrial abnormalities: preliminary results. J Clin Ultrasound 1993; 21:87.</a></li><li><a class="nounderline abstract_t">Syrop CH, Sahakian V. Transvaginal sonographic detection of endometrial polyps with fluid contrast augmentation. Obstet Gynecol 1992; 79:1041.</a></li><li><a class="nounderline abstract_t">American College of Obstetricians and Gynecologists. ACOG Technology Assessment in Obstetrics and Gynecology No. 5: sonohysterography. Obstet Gynecol 2008; 112:1467.</a></li><li><a class="nounderline abstract_t">Guideline developed in collaboration with the American College of Radiology, American College of Obstetricians and Gynecologists, Society of Radiologists in Ultrasound. AIUM Practice Guideline for the Performance of Sonohysterography. J Ultrasound Med 2015; 34:1.</a></li><li class="breakAll">APGO educational series on women's health issues. Clinical management of abnormal uterine bleeding. Association of Professors of Gynecology and Obstetrics, 2006.</li><li><a class="nounderline abstract_t">Goldstein RB, Bree RL, Benson CB, et al. Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference statement. J Ultrasound Med 2001; 20:1025.</a></li><li><a class="nounderline abstract_t">La Sala GB, Blasi I, Gallinelli A, et al. Diagnostic accuracy of sonohysterography and transvaginal sonography as compared with hysteroscopy and endometrial biopsy: a prospective study. Minerva Ginecol 2011; 63:421.</a></li><li><a class="nounderline abstract_t">Kamel HS, Darwish AM, Mohamed SA. Comparison of transvaginal ultrasonography and vaginal sonohysterography in the detection of endometrial polyps. Acta Obstet Gynecol Scand 2000; 79:60.</a></li><li><a class="nounderline abstract_t">Epstein E, Ramirez A, Skoog L, Valentin L. Transvaginal sonography, saline contrast sonohysterography and hysteroscopy for the investigation of women with postmenopausal bleeding and endometrium &gt; 5 mm. Ultrasound Obstet Gynecol 2001; 18:157.</a></li><li><a class="nounderline abstract_t">Schwärzler P, Concin H, Bösch H, et al. An evaluation of sonohysterography and diagnostic hysteroscopy for the assessment of intrauterine pathology. Ultrasound Obstet Gynecol 1998; 11:337.</a></li><li><a class="nounderline abstract_t">Krampl E, Bourne T, Hurlen-Solbakken H, Istre O. Transvaginal ultrasonography sonohysterography and operative hysteroscopy for the evaluation of abnormal uterine bleeding. Acta Obstet Gynecol Scand 2001; 80:616.</a></li><li><a class="nounderline abstract_t">Soares SR, Barbosa dos Reis MM, Camargos AF. Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases. Fertil Steril 2000; 73:406.</a></li><li><a class="nounderline abstract_t">de Kroon CD, Jansen FW, Louwé LA, et al. Technology assessment of saline contrast hysterosonography. Am J Obstet Gynecol 2003; 188:945.</a></li><li><a class="nounderline abstract_t">Goldstein SR, Zeltser I, Horan CK, et al. Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding. Am J Obstet Gynecol 1997; 177:102.</a></li><li><a class="nounderline abstract_t">Salle B, Gaucherand P, de Saint Hilaire P, Rudigoz RC. Transvaginal sonohysterographic evaluation of intrauterine adhesions. J Clin Ultrasound 1999; 27:131.</a></li><li><a class="nounderline abstract_t">Darwish AM, Youssef AA. Screening sonohysterography in infertility. Gynecol Obstet Invest 1999; 48:43.</a></li><li><a class="nounderline abstract_t">Ludwin A, Ludwin I, Banas T, et al. Diagnostic accuracy of sonohysterography, hysterosalpingography and diagnostic hysteroscopy in diagnosis of arcuate, septate and bicornuate uterus. J Obstet Gynaecol Res 2011; 37:178.</a></li><li><a class="nounderline abstract_t">Luciano DE, Exacoustos C, Johns DA, Luciano AA. Can hysterosalpingo-contrast sonography replace hysterosalpingography in confirming tubal blockage after hysteroscopic sterilization and in the evaluation of the uterus and tubes in infertile patients? Am J Obstet Gynecol 2011; 204:79.e1.</a></li><li><a class="nounderline abstract_t">Luciano DE, Exacoustos C, Luciano AA. Contrast ultrasonography for tubal patency. J Minim Invasive Gynecol 2014; 21:994.</a></li><li><a class="nounderline abstract_t">Lindheim SR, Sprague C, Winter TC 3rd. Hysterosalpingography and sonohysterography: lessons in technique. AJR Am J Roentgenol 2006; 186:24.</a></li><li><a class="nounderline abstract_t">Piccioni MG, Riganelli L, Filippi V, et al. Sonohysterosalpingography: Comparison of foam and saline solution. J Clin Ultrasound 2017; 45:67.</a></li><li><a class="nounderline abstract_t">Goldstein SR. Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 1994; 170:447.</a></li><li><a class="nounderline abstract_t">Hann LE, Gretz EM, Bach AM, Francis SM. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen. AJR Am J Roentgenol 2001; 177:337.</a></li><li><a class="nounderline abstract_t">Elhelw B, Ghorab MN, Farrag SH. Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen. Int J Gynaecol Obstet 1999; 67:81.</a></li><li><a class="nounderline abstract_t">Schwartz LB, Snyder J, Horan C, et al. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen. Ultrasound Obstet Gynecol 1998; 11:48.</a></li><li><a class="nounderline abstract_t">Committee Opinion No. 601: Tamoxifen and uterine cancer. Obstet Gynecol 2014; 123:1394. Reaffirmed 2021.</a></li><li><a class="nounderline abstract_t">Goldstein SR. Controversy about uterine effects and safety of SERMs: the saga continues. Menopause 2002; 9:381.</a></li><li><a class="nounderline abstract_t">Wolman I, Groutz A, Gordon D, et al. Timing of sonohysterography in menstruating women. Gynecol Obstet Invest 1999; 48:254.</a></li><li><a class="nounderline abstract_t">Yung SS, Lai SF, Lam MT, et al. Randomized, controlled, double-blind trial of topical lidocaine gel and intrauterine lidocaine infusion for pain relief during saline contrast sonohysterography. Ultrasound Obstet Gynecol 2016; 47:17.</a></li><li><a class="nounderline abstract_t">Dessole S, Farina M, Capobianco G, et al. Determining the best catheter for sonohysterography. Fertil Steril 2001; 76:605.</a></li><li><a class="nounderline abstract_t">Sylvestre C, Child TJ, Tulandi T, Tan SL. A prospective study to evaluate the efficacy of two- and three-dimensional sonohysterography in women with intrauterine lesions. Fertil Steril 2003; 79:1222.</a></li><li><a class="nounderline abstract_t">Exalto N, Stappers C, van Raamsdonk LA, Emanuel MH. Gel instillation sonohysterography: first experience with a new technique. Fertil Steril 2007; 87:152.</a></li><li><a class="nounderline abstract_t">Davis PC, O'Neill MJ, Yoder IC, et al. Sonohysterographic findings of endometrial and subendometrial conditions. Radiographics 2002; 22:803.</a></li><li><a class="nounderline abstract_t">Sanin-Ramirez D, Carriles I, Graupera B, et al. Two-dimensional transvaginal sonography vs saline contrast sonohysterography for diagnosing endometrial polyps: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2020; 56:506.</a></li><li><a class="nounderline abstract_t">Timmerman D, Verguts J, Konstantinovic ML, et al. The pedicle artery sign based on sonography with color Doppler imaging can replace second-stage tests in women with abnormal vaginal bleeding. Ultrasound Obstet Gynecol 2003; 22:166.</a></li><li><a class="nounderline abstract_t">Becker E Jr, Lev-Toaff AS, Kaufman EP, et al. The added value of transvaginal sonohysterography over transvaginal sonography alone in women with known or suspected leiomyoma. J Ultrasound Med 2002; 21:237.</a></li><li><a class="nounderline abstract_t">Bittencourt CA, Dos Santos Simões R, Bernardo WM, et al. Accuracy of saline contrast sonohysterography in detection of endometrial polyps and submucosal leiomyomas in women of reproductive age with abnormal uterine bleeding: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2017; 50:32.</a></li><li><a class="nounderline abstract_t">Reeves MF, Goldstein RB, Jones KD. Communication of adenomyosis with the endometrial cavity: visualization with saline contrast sonohysterography. Ultrasound Obstet Gynecol 2010; 36:115.</a></li><li><a class="nounderline abstract_t">Tocci A, Greco E, Ubaldi FM. Adenomyosis and 'endometrial-subendometrial myometrium unit disruption disease' are two different entities. Reprod Biomed Online 2008; 17:281.</a></li><li><a class="nounderline abstract_t">Ahonkallio SJ, Liakka AK, Martikainen HK, Santala MJ. Feasibility of endometrial assessment after thermal ablation. Eur J Obstet Gynecol Reprod Biol 2009; 147:69.</a></li><li><a class="nounderline abstract_t">Cooper JM, Brady RM. Intraoperative and early postoperative complications of operative hysteroscopy. Obstet Gynecol Clin North Am 2000; 27:347.</a></li><li><a class="nounderline abstract_t">Tuveng JM, Vold I, Jerve F, et al. Hysterosalpingography: value in estimating tubal function, and risk of infectious complications. Acta Eur Fertil 1985; 16:125.</a></li><li><a class="nounderline abstract_t">ACOG Practice Bulletin No. 195: Prevention of Infection After Gynecologic Procedures. Obstet Gynecol 2018; 131:e172. Reaffirmed 2022.</a></li><li><a class="nounderline abstract_t">Bese T, Demirkiran F, Guralp O, et al. Transtubal transport of carcinoma cells into the peritoneal cavity after saline infusion via transcervical route in patients with endometrial carcinoma. Int J Gynecol Cancer 2009; 19:682.</a></li><li><a class="nounderline abstract_t">Alcázar JL, Errasti T, Zornoza A. Saline infusion sonohysterography in endometrial cancer: assessment of malignant cells dissemination risk. Acta Obstet Gynecol Scand 2000; 79:321.</a></li><li><a class="nounderline abstract_t">Dessole S, Rubattu G, Farina M, et al. Risks and usefulness of sonohysterography in patients with endometrial carcinoma. Am J Obstet Gynecol 2006; 194:362.</a></li><li><a class="nounderline abstract_t">Lindheim SR, Morales AJ. Comparison of sonohysterography and hysteroscopy: lessons learned and avoiding pitfalls. J Am Assoc Gynecol Laparosc 2002; 9:223.</a></li><li><a class="nounderline abstract_t">Mihm LM, Quick VA, Brumfield JA, et al. The accuracy of endometrial biopsy and saline sonohysterography in the determination of the cause of abnormal uterine bleeding. Am J Obstet Gynecol 2002; 186:858.</a></li><li><a class="nounderline abstract_t">Dessole S, Farina M, Rubattu G, et al. Side effects and complications of sonohysterosalpingography. Fertil Steril 2003; 80:620.</a></li><li><a class="nounderline abstract_t">van Dongen H, de Kroon CD, van den Tillaart SA, et al. A randomised comparison of vaginoscopic office hysteroscopy and saline infusion sonography: a patient compliance study. BJOG 2008; 115:1232.</a></li></ol></div><div id="topicVersionRevision">Topic 3252 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8381140" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Sonohysterography for endometrial abnormalities: preliminary results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1579303" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Transvaginal sonographic detection of endometrial polyps with fluid contrast augmentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19037058" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : ACOG Technology Assessment in Obstetrics and Gynecology No. 5: sonohysterography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26206817" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : AIUM Practice Guideline for the Performance of Sonohysterography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26206817" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : AIUM Practice Guideline for the Performance of Sonohysterography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11587008" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21926951" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Diagnostic accuracy of sonohysterography and transvaginal sonography as compared with hysteroscopy and endometrial biopsy: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10646818" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Comparison of transvaginal ultrasonography and vaginal sonohysterography in the detection of endometrial polyps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11529998" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Transvaginal sonography, saline contrast sonohysterography and hysteroscopy for the investigation of women with postmenopausal bleeding and endometrium&gt;5 mm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9644773" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : An evaluation of sonohysterography and diagnostic hysteroscopy for the assessment of intrauterine pathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11437719" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Transvaginal ultrasonography sonohysterography and operative hysteroscopy for the evaluation of abnormal uterine bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10685551" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12712091" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Technology assessment of saline contrast hysterosonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9240591" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10064410" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Transvaginal sonohysterographic evaluation of intrauterine adhesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10394091" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Screening sonohysterography in infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21314802" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Diagnostic accuracy of sonohysterography, hysterosalpingography and diagnostic hysteroscopy in diagnosis of arcuate, septate and bicornuate uterus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21187197" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Can hysterosalpingo-contrast sonography replace hysterosalpingography in confirming tubal blockage after hysteroscopic sterilization and in the evaluation of the uterus and tubes in infertile patients?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24910933" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Contrast ultrasonography for tubal patency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16357372" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Hysterosalpingography and sonohysterography: lessons in technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27753111" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Sonohysterosalpingography: Comparison of foam and saline solution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8116695" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11461858" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10636051" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9511196" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24848920" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Committee Opinion No. 601: Tamoxifen and uterine cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12218728" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Controversy about uterine effects and safety of SERMs: the saga continues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10592428" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Timing of sonohysterography in menstruating women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26434382" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Randomized, controlled, double-blind trial of topical lidocaine gel and intrauterine lidocaine infusion for pain relief during saline contrast sonohysterography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11532488" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Determining the best catheter for sonohysterography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12738522" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : A prospective study to evaluate the efficacy of two- and three-dimensional sonohysterography in women with intrauterine lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17097650" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Gel instillation sonohysterography: first experience with a new technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12110711" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Sonohysterographic findings of endometrial and subendometrial conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32730635" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Two-dimensional transvaginal sonography vs saline contrast sonohysterography for diagnosing endometrial polyps: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12905512" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The pedicle artery sign based on sonography with color Doppler imaging can replace second-stage tests in women with abnormal vaginal bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11883534" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : The added value of transvaginal sonohysterography over transvaginal sonography alone in women with known or suspected leiomyoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27862503" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Accuracy of saline contrast sonohysterography in detection of endometrial polyps and submucosal leiomyomas in women of reproductive age with abnormal uterine bleeding: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20069662" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Communication of adenomyosis with the endometrial cavity: visualization with saline contrast sonohysterography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18682005" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Adenomyosis and 'endometrial-subendometrial myometrium unit disruption disease' are two different entities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19615812" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Feasibility of endometrial assessment after thermal ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10857125" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Intraoperative and early postoperative complications of operative hysteroscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3929521" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Hysterosalpingography: value in estimating tubal function, and risk of infectious complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29794678" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : ACOG Practice Bulletin No. 195: Prevention of Infection After Gynecologic Procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19509571" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Transtubal transport of carcinoma cells into the peritoneal cavity after saline infusion via transcervical route in patients with endometrial carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10746850" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Saline infusion sonohysterography in endometrial cancer: assessment of malignant cells dissemination risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16458630" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Risks and usefulness of sonohysterography in patients with endometrial carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11960054" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Comparison of sonohysterography and hysteroscopy: lessons learned and avoiding pitfalls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12015495" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The accuracy of endometrial biopsy and saline sonohysterography in the determination of the cause of abnormal uterine bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12969709" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Side effects and complications of sonohysterosalpingography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18715407" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : A randomised comparison of vaginoscopic office hysteroscopy and saline infusion sonography: a patient compliance study.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
